AI-generated summary
The authors report on eleven meta-analyses from the MASCC Oncodermatology study group about preventing and managing acute radiation dermatitis. They analyzed 51 randomized controlled trials identified from literature searched from 1946 to January 2023, covering a range of interventions including photobiomodulation therapy. The abstract describes the collection as informing updated clinical practice guidelines.
- Studies included
- 51
- Who or what was studied
- Patients with acute radiation dermatitis during cancer radiotherapy, as covered by randomized controlled trials
- Limits stated in the abstract
- The abstract does not report the certainty of the evidence or the effect sizes for individual interventions, including photobiomodulation therapy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Systematic review. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.